Focus on myeloproliferative diseases and myelodysplastic syndromes

Cancer Cell. 2004 Dec;6(6):547-52. doi: 10.1016/j.ccr.2004.12.004.
No abstract available

Publication types

  • Review

MeSH terms

  • Anemia, Refractory / genetics
  • Anemia, Refractory / pathology
  • Anemia, Refractory / therapy
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelomonocytic, Chronic / genetics
  • Leukemia, Myelomonocytic, Chronic / pathology
  • Leukemia, Myelomonocytic, Chronic / therapy
  • Models, Biological
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / pathology*
  • Myelodysplastic Syndromes / therapy
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / pathology*
  • Myeloproliferative Disorders / therapy
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use
  • Signal Transduction / genetics

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate